Search Results - "Torbicki, Adam"

Validation Analysis of the Polish-Translated Version of EmPHasis-10 Health-Related Quality of Life Questionnaire in Patients with Pulmonary Arterial Hypertension.

Authors: Wieteska-Miłek, Maria Tkaczyk, Dominika Torbicki, Adam et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 5, p2020. 12p.

Effect of Macitentan in Pulmonary Arterial Hypertension and the Relationship Between Echocardiography and cMRI Variables: REPAIR Echocardiography Sub-study Results.

Authors: Torbicki, Adam Channick, Richard Galiè, Nazzareno et al.

Source: Cardiology & Therapy. Mar2024, Vol. 13 Issue 1, p173-190. 18p.

Sex-Specific Differences in Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Authors: Kurzyna, Paweł Witowicz, Anna Kędzierski, Piotr et al.

Source: Journal of Clinical Medicine. Feb2025, Vol. 14 Issue 3, p899. 16p.

Safety and Outcomes of Inferior Vena Cava Filter Placement in Oncology Patients: A Single-Centre Experience.

Authors: Kurzyna, Paweł Banaszkiewicz, Marta Florczyk, Michał et al.

Source: Cancers. Apr2024, Vol. 16 Issue 8, p1562. 11p.

Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat.

Authors: Oknińska, Marta Paterek, Aleksandra Grzanka, Małgorzata et al.

Source: British Journal of Pharmacology. Oct2024, Vol. 181 Issue 20, p4050-4066. 17p.

Precision medicine: The future of diagnostic approach to pulmonary hypertension?

Authors: Kedzierski, Piotr Torbicki, Adam

Source: Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. Oct2019, Vol. 22 Issue 4, p168-171. 4p.

The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Authors: Piłka, Michał Darocha, Szymon Florczyk, Michał et al.

Source: Journal of Clinical Medicine. Dec2023, Vol. 12 Issue 24, p7621. 11p.

Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.

Authors: Oknińska, Marta Zambrowska, Zuzanna Zajda, Karolina et al.

Source: Scientific Reports. 9/9/2021, Vol. 11 Issue 1, p1-9. 9p.

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.

Authors: Jansa, Pavel Kopeć, Grzegorz Torbicki, Adam et al.

Source: Pulmonary Circulation. Jul2023, Vol. 13 Issue 3, p1-10. 10p.

Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.

Authors: McLaughlin, Vallerie V. Sitbon, Olivier Chin, Kelly M. et al.

Source: European Journal of Heart Failure. Nov2024, Vol. 26 Issue 11, p2379-2391. 13p.

Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation.

Authors: Siniarski, Aleksander Gąsecka, Aleksandra Starczyński, Miłosz et al.

Source: Platelets. 2022, Vol. 33 Issue 7, p1065-1074. 10p.

Pulmonary Hypertension: Diagnosis and Management.

Authors: Torbicki, Adam¹ (AUTHOR) adam.torbicki@ecz-otwock.pl

Source: Diagnostics (2075-4418). Jun2021, Vol. 11 Issue 6, p1066-1066. 1p.

Milestones in Understanding Pulmonary Circulation: From Antiquity to Heart-Lung Machine.

Authors: Torbicki, Adam Grenier, Philippe A.

Source: Diagnostics (2075-4418). Feb2021, Vol. 11 Issue 2, p381-381. 1p.

Changes in Estimated Glomerular Filtration after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Authors: Darocha, Szymon Banaszkiewicz, Marta Pietrasik, Arkadiusz et al.

Source: CardioRenal Medicine. 2020, Vol. 10 Issue 1, p22-31. 10p.

Soluble ST2 protein as a new biomarker in patients with precapillary pulmonary hypertension.

Authors: Banaszkiewicz, Marta Pietrasik, Arkadiusz Darocha, Szymon et al.

Source: Archives of Medical Science. 2024, Vol. 20 Issue 5, p1442-1451. 10p.

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience.

Authors: Pietrasik, Arkadiusz Gąsecka, Aleksandra Kurzyna, Paweł et al.

Source: Journal of Clinical Medicine. Jul2022, Vol. 11 Issue 13, p3812-N.PAG. 14p.

The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.

Authors: Olschewski, Horst Torbicki, Adam

Source: Diagnostics (2075-4418). Feb2021, Vol. 11 Issue 2, p311-311. 1p.

Anunusual case ofCTEPHtreated byBPAin a patient with a single lung after cancer surgery.

Authors: Darocha, Szymon Kurzyna, Paweł Banaszkiewicz‐Cyganik, Marta et al.

Source: Pulmonary Circulation. Apr2022, Vol. 12 Issue 2, p1-5. 5p.

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension.

Authors: Kacprzak, Aneta Burakowska, Barbara Kurzyna, Marcin et al.

Source: Respiratory Research. 11/17/2021, Vol. 22 Issue 1, p1-11. 11p.

Acute coronary syndrome caused by compression of the left main coronary artery -- the usefulness of computed tomography in diagnosis and interventional treatment planning.

Alternate Title: Ostry zespóś wiełcowy spowodowany kompresją pnia lewej tńtnicy wiełcowej -- przydatnoąć tomografii komputerowej w rozpoznaniu i planowaniu leczenia interwencyjnego.

Authors: Kńpka, Cezary Dzieliłska, Zofia Torbicki, Adam et al.

Source: Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej. 2012, Vol. 8 Issue 1, p61-65. 5p.